Advised on the Placement of Equity

Healthcare

Undisclosed Investors

Undisclosed Investors United Kingdom of Great Britain and Northern Ireland

Provided Financing

Acacia Pharma

commercial stage biopharmaceutical United Kingdom of Great Britain and Northern Ireland

Completed the Initial Global Offering (IGO) of Acacia Pharma at Euronext Brussels

Completed the Initial Global Offering (IGO) of Acacia Pharma at Euronext Brussels. Acted as Joint Global Coordinator and Bookrunner for this transaction, consisting of a private placement followed by the admission onto the regulated market.